Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T72458 | Target Info | |||
Target Name | Melanocortin receptor 4 (MC4R) | ||||
Synonyms |
MC4-R
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | MC4R | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Opioid receptor mu (MOP) | Successful Target | ||||
UniProt ID | OPRM_HUMAN | |||||
Gene Name | OPRM1 | |||||
Synonyms |
hMOP; Mu-type opioid receptor; Mu opioid receptor; Mu opiate receptor; MOR1A; MOR1; MOR-1; M-OR-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Methylnaltrexone bromide | Drug Info | Ki = 5.48 nM | [1] | ||
Co-Target Name | Opioid receptor delta (OPRD1) | Successful Target | ||||
UniProt ID | OPRD_HUMAN | |||||
Gene Name | OPRD1 | |||||
Synonyms |
OPRD; Delta-type opioid receptor; Delta opioid receptor; DOR-1; D-OR-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Methylnaltrexone bromide | Drug Info | Ki = 501.19 nM | [2] | ||
Co-Target Name | Vasopressin V1a receptor (V1AR) | Successful Target | ||||
UniProt ID | V1AR_HUMAN | |||||
Gene Name | AVPR1A | |||||
Synonyms |
Vascular/hepatic-type arginine vasopressin receptor; V1aR; V1a vasopressin receptor; Antidiuretic hormone receptor 1a; AVPR1; AVPR V1a
Click to Show/Hide
|
|||||
Representative Drug(s) | PMX-53 | Drug Info | IC50 = 740 nM | [3] | ||
Co-Target Name | Melanocortin receptor 1 (MC1R) | Clinical trial Target | ||||
UniProt ID | MSHR_HUMAN | |||||
Gene Name | MC1R | |||||
Synonyms |
Melanotropin receptor; Melanocyte-stimulating hormone receptor; Melanocortin-1 receptor; MSHR; MSH-R; MC1-R
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | EC50 = 0.0955 nM | [4] | |||
Co-Target Name | C5a anaphylatoxin chemotactic receptor (C5AR1) | Successful Target | ||||
UniProt ID | C5AR1_HUMAN | |||||
Gene Name | C5AR1 | |||||
Synonyms |
CD88; C5aR; C5a-R; C5a anaphylatoxin chemotactic receptor 1; C5R1
Click to Show/Hide
|
|||||
Representative Drug(s) | PMX-53 | Drug Info | IC50 = 15 nM | [5] | ||
Co-Target Name | Melanocortin receptor 5 (MC5R) | Clinical trial Target | ||||
UniProt ID | MC5R_HUMAN | |||||
Gene Name | MC5R | |||||
Synonyms |
MC5-R; MC2; MC-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 17 nM | [6] | |||
Co-Target Name | Substance-K receptor (TACR2) | Clinical trial Target | ||||
UniProt ID | NK2R_HUMAN | |||||
Gene Name | TACR2 | |||||
Synonyms |
Tachykinin receptor 2; Tachykinin neurokinin 2 receptor; TACR2; SKR; Neurokinin A receptor; NK-2R; NK-2 receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | PMX-53 | Drug Info | IC50 = 87 nM | [3] | ||
Co-Target Name | Melanocortin receptor 3 (MC3R) | Literature-reported Target | ||||
UniProt ID | MC3R_HUMAN | |||||
Gene Name | MC3R | |||||
Synonyms |
MC3-R
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | EC50 = 2.399 nM | [4] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of naldemedine: A potent and orally available opioid receptor antagonist for treatment of opioid-induced adverse effects. Bioorg Med Chem Lett. 2019 Jan 1;29(1):73-77. | ||||
REF 2 | Discovery of Axelopran (TD-1211): A Peripherally Restricted mu-Opioid Receptor Antagonist. ACS Med Chem Lett. 2019 Nov 26;10(12):1641-1647. | ||||
REF 3 | Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92. | ||||
REF 4 | Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1. J Med Chem. 2018 Apr 26;61(8):3674-3684. | ||||
REF 5 | Selective hexapeptide agonists and antagonists for human complement C3a receptor. J Med Chem. 2010 Jul 8;53(13):4938-48. | ||||
REF 6 | Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selective alpha-melanocyte-stimulating hormone (alpha-MSH) analogues. J Med Chem. 2012 Mar 8;55(5):1969-77. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.